Literature DB >> 11232136

New insights into the physiology and pharmacology of vitamin C.

S J Padayatty1, M Levine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11232136      PMCID： PMC80729     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  14 in total

1.  The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer.

Authors:  E Cameron; A Campbell
Journal:  Chem Biol Interact       Date:  1974-10       Impact factor: 5.192

2.  Experimental scurvy in man.

Authors:  R E Hodges; E M Baker; J Hood; H E Sauberlich; S C March
Journal:  Am J Clin Nutr       Date:  1969-05       Impact factor: 7.045

3.  Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance.

Authors:  M Levine; C Conry-Cantilena; Y Wang; R W Welch; P W Washko; K R Dhariwal; J B Park; A Lazarev; J F Graumlich; J King; L R Cantilena
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

4.  A family of mammalian Na+-dependent L-ascorbic acid transporters.

Authors:  H Tsukaguchi; T Tokui; B Mackenzie; U V Berger; X Z Chen; Y Wang; R F Brubaker; M A Hediger
Journal:  Nature       Date:  1999-05-06       Impact factor: 49.962

5.  Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.

Authors:  E T Creagan; C G Moertel; J R O'Fallon; A J Schutt; M J O'Connell; J Rubin; S Frytak
Journal:  N Engl J Med       Date:  1979-09-27       Impact factor: 91.245

6.  National Cancer Institute's evaluation of unconventional cancer treatments.

Authors:  M J Hawkins; M A Friedman
Journal:  J Natl Cancer Inst       Date:  1992-11-18       Impact factor: 13.506

7.  Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer.

Authors:  E Cameron; L Pauling
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

8.  Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent.

Authors:  N H Riordan; H D Riordan; X Meng; Y Li; J A Jackson
Journal:  Med Hypotheses       Date:  1995-03       Impact factor: 1.538

9.  Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.

Authors:  E Cameron; L Pauling
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

10.  High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.

Authors:  C G Moertel; T R Fleming; E T Creagan; J Rubin; M J O'Connell; M M Ames
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245
View more
  45 in total

1.  Proof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapies.

Authors:  L J Hoffer
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

2.  Exploring the actions of vitamin C.

Authors:  U N Das
Journal:  CMAJ       Date:  2001-07-10       Impact factor: 8.262

3.  Nitroso-redox status and vascular function in marginal and severe ascorbate deficiency.

Authors:  Maria-Francisca Garcia-Saura; Fumito Saijo; Nathan S Bryan; Selena Bauer; Juan Rodriguez; Martin Feelisch
Journal:  Antioxid Redox Signal       Date:  2012-03-08       Impact factor: 8.401

4.  Vitamin C: new role of the old vitamin in the cardiovascular system?

Authors:  Csaba Kónya; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

5.  Nutrition, anabolism, and the wound healing process: an overview.

Authors:  Robert H Demling
Journal:  Eplasty       Date:  2009-02-03

6.  Extensive bruising secondary to vitamin C deficiency.

Authors:  Ian Mark Fraser; Mark Dean
Journal:  BMJ Case Rep       Date:  2009-02-26

Review 7.  A combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon.

Authors:  Ines Batinic-Haberle; Zrinka Rajic; Ludmil Benov
Journal:  Anticancer Agents Med Chem       Date:  2011-05-01       Impact factor: 2.505

8.  Reply to Yew et al., "Vitamin C and Mycobacterium tuberculosis Persisters".

Authors:  Catherine Vilchèze; William R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

9.  Oxidative stress in the hippocampus during experimental seizures can be ameliorated with the antioxidant ascorbic acid.

Authors:  Itala Mônica Sales Santos; Adriana da Rocha Tomé; Gláucio Barros Saldanha; Paulo Michel Pinheiro Ferreira; Gardenia Carmem Gadelha Militão; Rivelilson Mendes de Freitas
Journal:  Oxid Med Cell Longev       Date:  2009 Sep-Oct       Impact factor: 6.543

10.  Inability to walk due to scurvy: A forgotten disease.

Authors:  Hussein A Algahtani; Abduljaleel P Abdu; Imad M Khojah; Ali M Al-Khathaami
Journal:  Ann Saudi Med       Date:  2010 Jul-Aug       Impact factor: 1.526
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.